These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11331577)

  • 1. Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions.
    Parham SN; Resende CG; Tuite MF
    EMBO J; 2001 May; 20(9):2111-9. PubMed ID: 11331577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligopeptide-repeat expansions modulate 'protein-only' inheritance in yeast.
    Liu JJ; Lindquist S
    Nature; 1999 Aug; 400(6744):573-6. PubMed ID: 10448860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structure and functional similarity of yeast Sup35p and Ure2p proteins to mammalian prions].
    Kushnirov VV; Ter-Avanesian MD; Smirnov VN
    Mol Biol (Mosk); 1995; 29(4):750-5. PubMed ID: 7476941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fusion of glutathione S-transferase with the N-terminus of yeast Sup35p protein inhibits its prion-like properties].
    Dagkesamanskaia AR; Kushnirov VV; Paushkin SV; Ter-Avanesian MD
    Genetika; 1997 May; 33(5):610-5. PubMed ID: 9273317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a human [psi]?
    Jean-Jean O; Le Goff X; Philippe M
    C R Acad Sci III; 1996 Jun; 319(6):487-92. PubMed ID: 8881282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of conformational flexibility in prion propagation and maintenance for Sup35p.
    Scheibel T; Lindquist SL
    Nat Struct Biol; 2001 Nov; 8(11):958-62. PubMed ID: 11685242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of budding yeast prion-determinant sequences across diverse fungi.
    Harrison LB; Yu Z; Stajich JE; Dietrich FS; Harrison PM
    J Mol Biol; 2007 Apr; 368(1):273-82. PubMed ID: 17320905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein/protein interactions: fusion with yeast Sup35p-NM modulates cytosolic PrP aggregation in mammalian cells.
    Krammer C; Suhre MH; Kremmer E; Diemer C; Hess S; Schätzl HM; Scheibel T; Vorberg I
    FASEB J; 2008 Mar; 22(3):762-73. PubMed ID: 17928365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chimeric yeast prions with unstable inheritance].
    Borkhsenius AS; Sasnauskas K; Gedvilaĭte A; Inge-Vechtomov SG
    Genetika; 2002 Mar; 38(3):300-5. PubMed ID: 11963556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion properties of the Sup35 protein of yeast Pichia methanolica.
    Kushnirov VV; Kochneva-Pervukhova NV; Chechenova MB; Frolova NS; Ter-Avanesyan MD
    EMBO J; 2000 Feb; 19(3):324-31. PubMed ID: 10654931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of divalent copper, manganese and zinc ions on fibril nucleation and elongation of the amyloid-like yeast prion determinant Sup35p-NM.
    Suhre MH; Hess S; Golser AV; Scheibel T
    J Inorg Biochem; 2009 Dec; 103(12):1711-20. PubMed ID: 19853305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor.
    Paushkin SV; Kushnirov VV; Smirnov VN; Ter-Avanesyan MD
    EMBO J; 1996 Jun; 15(12):3127-34. PubMed ID: 8670813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation within the C-terminal domain of Sup35p that affects [PSI+] prion propagation.
    Kabani M; Cosnier B; Bousset L; Rousset JP; Melki R; Fabret C
    Mol Microbiol; 2011 Aug; 81(3):640-58. PubMed ID: 21631606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitting yeast and mammalian prion aggregation kinetic data with the Finke-Watzky two-step model of nucleation and autocatalytic growth.
    Watzky MA; Morris AM; Ross ED; Finke RG
    Biochemistry; 2008 Oct; 47(40):10790-800. PubMed ID: 18785757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibition of Psi+ prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein.
    Kochneva-Pervukhova NV; Paushkin SV; Kushnirov VV; Cox BS; Tuite MF; Ter-Avanesyan MD
    EMBO J; 1998 Oct; 17(19):5805-10. PubMed ID: 9755180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the N-terminal oligopeptide repeats of the yeast Sup35 prion protein in propagation and transmission of prion variants.
    Shkundina IS; Kushnirov VV; Tuite MF; Ter-Avanesyan MD
    Genetics; 2006 Feb; 172(2):827-35. PubMed ID: 16272413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein.
    Chernoff YO; Galkin AP; Lewitin E; Chernova TA; Newnam GP; Belenkiy SM
    Mol Microbiol; 2000 Feb; 35(4):865-76. PubMed ID: 10692163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supporting the structural basis of prion strains: induction and identification of [PSI] variants.
    King CY
    J Mol Biol; 2001 Apr; 307(5):1247-60. PubMed ID: 11292339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of prion transmission barriers by mutational control of amyloid conformations.
    Chien P; DePace AH; Collins SR; Weissman JS
    Nature; 2003 Aug; 424(6951):948-51. PubMed ID: 12931190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PSI+] maintenance is dependent on the composition, not primary sequence, of the oligopeptide repeat domain.
    Toombs JA; Liss NM; Cobble KR; Ben-Musa Z; Ross ED
    PLoS One; 2011; 6(7):e21953. PubMed ID: 21760933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.